Fortress Biotech Announces Closing of Acquisition of Caelum Biosciences by AZ
06 Oct 2021 //
GLOBENEWSWIRE
Non-genetic amyloidosis lives again, thanks to Darzalex and Astra
29 Sep 2021 //
EVALUATE
Fortress Biotech Announces Receipt of Notice of Option Exercise from AZ
29 Sep 2021 //
GLOBENEWSWIRE
AstraZeneca to buy rare-disease specialist Caelum in potential $500 million deal
28 Sep 2021 //
REUTERS
Caelum and Alexion Present Phase 2 Data on Safety and Tolerability of CAEL-101
11 Jun 2021 //
BUSINESSWIRE
Caelum and Alexion Present Phase 2 Data on Safety and Tolerability of CAEL-101
11 Jun 2021 //
BUSINESSWIRE
Caelum & Alexion Announce Upcoming CAEL-101 Data Presentations at the EHA 2021
12 May 2021 //
BUSINESSWIRE